Enzyme-linked immunosorbent assay (ELISA) and indirect immunofluorescence testing in a bullous pemphigoid and pemphigoid gestationis

International Journal of Dermatology

Volumn 47, Issue 12, 2008, Pages 1245-1249

  Barnadas, María A ^a   Rubiales, M Victòria ^a   González, M José ^a   Puig, Luis ^a   García, Pilar ^a   Baselga, Eulàlia ^a   Pujol, Ramón ^a   Alomar, Agustín ^a   Gelpí, Carmen ^a  

^a Hospital Sta Creu i St Pau ^*  (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G;

ADOLESCENT; ADULT; AGED; ARTICLE; BULLOUS PEMPHIGOID; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOFLUORESCENCE; INFANT; INTERMETHOD COMPARISON; MALE; PEMPHIGOID GESTATIONIS; SENSITIVITY AND SPECIFICITY;

ADOLESCENT; ADULT; AGED; AUTOANTIBODIES; AUTOANTIGENS; CHILD; CHILD, PRESCHOOL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HOMEODOMAIN PROTEINS; HUMANS; IMMUNOGLOBULIN G; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; NON-FIBRILLAR COLLAGENS; PEMPHIGOID GESTATIONIS; PEMPHIGOID, BULLOUS; PREDICTIVE VALUE OF TESTS; PREGNANCY; SENSITIVITY AND SPECIFICITY; SKIN; TRANSCRIPTION FACTORS; YOUNG ADULT;

EID: 57049087606     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2008.03824.x     Document Type: Article

References (25)

1. Gammon WR, Briggaman RA, Inman AO IIO, et al. Differentiating anti-lamina lucida and anti-subalamina densa anti-BMZ antibodies by immunofluorescence on 1.0 M sodium chloride separated skin. J Invest Dermatol 1984; 82: 139-144.
2. Gammon WR, Kowalewski C, Chorzelski TP, et al. Direct immunofluorescence studies of sodium chloride-separated skin in the differential diagnosis of bullous pemphigoid and epidermolysis bullosa acquisita. J Am Acad Dermatol 1990; 22: 664-670.
3. Liu Z, Díaz LA, Troy JL, et al. A passive transfer model of the organ-specific autoimmune disease, bullous pemphigoid, using antibodies generated against the desmosomal antigen, BP 180. J Clin Invest 1993; 92: 2480-2488.
4. Giudice GJ, Emery DJ, Zelickson BD, et al. Bullous pemphigoid and herpes gestationis autoantibodies recognize a common non-collagenous site on the BP180 ectodomain. J Immunol 1993; 151: 5742-5750.
5. Zillikens D, Rose PA, Balding SD, et al. Tight clustering of extracellular BP180 epitopes recognized by bullous pemphigoid autoantibodies. J Invest Dermatol 1997; 109: 573-579.
6. Giudice GJ, Wilske KC, Anhalt GJ, et al. Development of an ELISA to detect anti-BP180 autoanitibodies in bullous pemphigoid and herpes gestationis. J Invest Dermatol 1994; 102: 878-881.
7. Zillikens D, MascaróJM, Rose PA, et al. A highly sensitive enzyme-linked immunosorbent assay for the detection of circulating anti-BP180 autoantibodies in patients with bullous pemphigoid. J Invest Dermatol 1997; 109: 679-683.
8. Schmidt E, Obe K, Bröcker EB, et al. Serum levels of autoantibodies to BP180 correlate with disease activity in patients with bullous pemphigoid. Arch Dermatol 2000; 136: 174-178.
9. Nakatani C, Muramatsu T, Shirai T. Immunoreactivity of bullous pemphigoid (BP) autoantibodies against the NC16A and C-terminal domains of the 180 kDa BP antigen (BP180): Immunoblot analysis and enzyme-linked immunosorbent assay using BP180 recombinant proteins. Br J Dermatol 1998; 139: 365-370.
10. Haase C, Budinger L, Borradori L, et al. Detection of IgG autoantibodies in the sera of patients with bullous and gestational pemphigoid: ELISA studies using a baculovirus-encoded form of bullous pemphigoid antigen 2. J Invest Dermatol 1998; 110: 282-286.
11. Hata Y, Fujii Y, Tsunoda K, et al. Production of the entire extracellular domain of BP180 (type XVII collagen) by baculovirus expression. J Dermatol Sci 2000; 23: 183-190.
12. Amo Y, Ohkawa T, Tatsuta M, et al. Clinical significance of enzyme-linked immunosorbent assay for the detection of circulating anti-BP180 autoantibodies in patients with bullous pemphigoid. J Dermatol Sci 2001; 26: 14-18.
13. 2- and COOH-terminal regions of the BP180 ectodomain. J Invest Dermatol 2002: 1065-1073.
14. Mariotti F, Grosso F, Terracina M, et al. Development of a novel ELISA system for detection of anti-BP180 IgG and characterization of autoantibody profile in bullous pemphigoid patients. Br J Dermatol 2004; 151: 1004-1010.
15. Thoma-Uszynski S, Uter W, Schwietke S, et al. BP230- and BP180-specific auto-antibodies in bullous pemphigoid. J Invest Dermatol 2004; 122: 1413-1422.
16. Kobayashi M, Amagai M, Kuroda-Knoshita K, et al. BP180 ELISA using bacterial recombinant NC16a protein as a diagnostic and monitoring tool for bullous pemphigoid. J Dermatol Sci 2002; 30: 224-232.
17. Sitaru C, Powell J, Messer G, et al. Immunoblotting and enzyme-linked immunosorbent assay for the diagnosis of pemphigoid gestationis. Obst Gynecol 2004; 103: 757-763.
18. Sakuma-Oyama Y, Powell AM, Albert S, et al. Evaluation of a BP180-NC16a enzyme-linked immunosorbent assay in the initial diagnosis of bullous pemphigoid. Br J Dermatol 2004; 151: 126-131.
19. Tsuji-Abe Y, Akiyama M, Yamanaka Y, et al. Correlation of clinical severity and ELISA indices for the NC16A domain of BP180 measured using BP 180 Elisa kit in bullous pemphigoid. J Dermatol Sci 2005; 37: 145-149.
20. Powell AM, Sakuma-Oyama Y, Oyama N, et al. Usefulness of BP180 NC16A enzyme-linked immunosorbent assay in the serodiagnosis of pemphigoid gestationis and in differentiating between pemphigoid gestationis and pruritic urticarial papules and plaques of pregnancy. Arch Dermatol 2005; 141: 705-710.
21. Barnadas MA, Gilaberte M, Pujol R, et al. Bullous pemphigoid in a patient with psoriasis during the course of PUVA therapy: Study by ELISA test. Int J Dermatol 2006; 45: 1089-1092.
22. Barnadas MA, Gelpi C, Curell R, et al. Repeat direct immunofluorescence (DIF) test, using 1.m NaCl treated skin, in the subepidermal autoimmune bullous diseases that contain IgG at the dermal epidermal junction. J Cutan Pathol 1999; 26: 37-41.
23. Smith EP, Taylor TB, Meyer LJ, et al. Antigen identification in drug-induced bullous pemphigoid. J Am Acad Dermatol 1993; 29: 879-882.
24. Ghohestani R, Kanitakis J, Nicolas JF, et al. Comparative sensitivity of indirect immunofluorescence to immunoblot for the detection of circulating antibodies to bullous pemphigoid antigens 1 and 2. Br J Dermatol, 1996; 135: 74-79.
25. Ghohestani RF, Cozzani E, Kanitakis J, et al. BP Ag2 antibodies are present at lower levels than BP Ag1 antibodies in serum from patients with bullous pemphigoid. Eur J Dermatol 1996; 6: 491-494.